[ad_1]
MINEOLA, NY – A new vaccination center has opened at NYU Langone – Long Island Hospital, formerly known as NYU Winthrop Hospital, which seeks to recruit 30,000 patients around the world for clinical trials of vaccines and treatments tests for the coronavirus, which causes COVID -19 disease.
The center recruits patients in a randomized, placebo-controlled trial. The trial aims to recruit patients between the ages of 18 and 85. Participants will receive two doses of the vaccine or a placebo saline solution.
Dr Steven Carsons, director of the hospital’s vaccination center, said it was exciting for the hospital to participate in COVID-19 vaccine trials.
“Vaccines were the biggest breakthrough against many deadly diseases, including smallpox, polio and measles – diseases that routinely killed thousands of people but lacked effective treatments,” Carsons said in A press release. “While emerging infectious diseases will always be a threat, COVID-19 is clearly the biggest health threat for a hundred years. By working together to put in place effective vaccines, we hope to defeat it.”
AstraZeneca vaccine designers worked with the University of Oxford to find out which of the virus’s protein components are most noticed by the immune system. The ingredients of effective vaccines teach the immune system which microbial invaders to attack in future encounters, thus providing protection for a period of time.
The new vaccination center is also looking to recruit residents of Long Island in future trials of experimental vaccines for other infectious diseases, such as influenza.
NYU Langone Health is one of 10 specialized vaccine and treatment assessment units nationwide funded by the National Institutes of Health.
Dr Mark Mulligan, Director of the Division of Infectious Diseases and Immunology and Director of NYU Langone Health Vaccine Center, said the new location brings “cutting-edge medical research” to patients, including those who are under-represented in clinical trials such as black, Hispanic and elderly people who are at higher than average risk of COVID-19 infection. Other patients at higher risk for COVID-19 include those with underlying illnesses such as heart disease, hypertension, asthma, chronic obstructive pulmonary disease, diabetes, or autoimmune disease.
[ad_2]
Source link